Is Acrivon Therapeutics, Inc. Common Stock (ACRV) undervalued? · $65.1M cap
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
This page asks whether Acrivon Therapeutics, Inc. Common Stock (ACRV) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued ACRV” is a slogan. Wait for the print.
ACRV currently screens at market cap $65.1M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ACRV 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ACRV to the stock page model before you treat a low multiple as a gift.
Not investment advice.